The GRPEL2 Knockout A-549 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population targeting the GRPEL2 gene, generated in the A-549 human lung adenocarcinoma cell line. This product provides a loss-of-function model system for studying GRPEL2-dependent mitochondrial processes. The polyclonal knockout population ensures a heterogeneous mix of edited alleles, enabling robust functional studies without clonal bias. This cellular tool is designed for researchers investigating mitochondrial protein import, proteostasis, and stress responses in the context of non-small cell lung cancer.
The A-549 host cell line is derived from human non-small cell lung carcinoma epithelial cells, isolated from a 58-year-old Caucasian male. A-549 cells are widely utilized as a model for lung adenocarcinoma, exhibiting characteristic epithelial morphology and maintaining key oncogenic signaling pathways. Their well-characterized biology and amenability to genetic manipulation make them an ideal platform for interrogating mitochondrial function in cancer. The knockout of GRPEL2 in this background allows the dissection of mitochondrial import defects within a disease-relevant cellular environment.
GRPEL2 encodes a mitochondrial nucleotide exchange factor that serves as a co-chaperone for mtHsp70 (HSPA9). It promotes ADP-ATP exchange on mtHsp70, driving the chaperone cycle essential for protein import into the mitochondrial matrix. Mechanistically, GRPEL2 interacts with HSPA9 and associates with the TIM23 translocase complex, including components such as PAM16 and DnaJC19/15. Its activity is regulated by upstream mitochondrial stress signals, and it functions downstream of transcriptional regulators like ATF5 and PGC-1??. Disruption of GRPEL2 impairs the proper import and folding of nuclear-encoded mitochondrial proteins, leading to proteotoxic stress and activation of the mitochondrial unfolded protein response (UPRmt). This response involves transcriptional upregulation of chaperones and proteases to restore mitochondrial homeostasis.
In A-549 lung adenocarcinoma cells, GRPEL2 knockout provides a unique opportunity to investigate how mitochondrial protein import defects influence cancer cell biology. Impaired mitochondrial function can alter metabolic adaptations, apoptosis sensitivity, and drug resistance mechanisms commonly observed in non-small cell lung cancer. The polyclonal nature of the knockout cell population allows the study of phenotypic heterogeneity and compensatory responses. Researchers can examine the interplay between mitochondrial proteostasis, UPRmt signaling, and the aggressive behavior of lung adenocarcinoma cells under varying stress conditions.
This knockout cell product is suitable for a range of research applications, including the mechanistic dissection of mitochondrial protein import pathways, screening for modulators of mitochondrial proteostasis, and investigating the role of GRPEL2 in drug resistance. Typical assays enabled by this model include Western blotting for GRPEL2 and mitochondrial markers, immunofluorescence for mitochondrial morphology, mitochondrial import assays using radiolabeled or fluorescent substrates, RT-qPCR profiling of UPRmt effector genes, and cell viability or apoptosis assays under stress challenge. For additional information, applications support, or custom services, please contact Ascent Research.
